Diet, H pylori infection and gastric cancer: Evidence and controversies

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 21

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

590

HTML

3648

Tables (1-6)

214

Sum=4452

Jun 7, 2007 (publication date) through Dec 1, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jun 7, 2007; 13(21): 2901-2912
Published online Jun 7, 2007. doi: 10.3748/wjg.v13.i21.2901

Table 3 Randomised controlled dietary intervention trials for prevention of stomach cancer

Author	Yr	Geographic area	Subjects n	Dietary intervention	Intervention (yr)	FU (yr)	Results
Wang GQ⁶⁷	1994	China	29584	retinol/zinc; riboflavin/niacin; Vit. C/molybdenum; carotene/Vit.E/selenium	5.25	5.25	↓ gastric cancer mortality
					5.25	5.25
Varis K⁶⁸	1998	Finland	29133	α-tocopherol 50 mg/d; β-carotene 20 mg/d;	5	5	= gastric cancer incidence
Malila N⁶⁹	2002	Finland	29133	α-tocopherol 50 mg/d; β-carotene 20 mg/d	5-8	8	= gastric cancer incidence
Zhu S⁷⁰	2003	China	216	Folate 20 mg/d + Vit. B12 1 mg/mo Natural β-carotene 30 mg/d Synthetic β-carotene 30 mg/d	2	8	No change cancer incidence ↓ precancerous lesions
Li H⁷¹	2004	China	2526	Synthetic allitridum 200 mg + selenium 100 mg	2	5	No change cancer incidence

FU: follow-up.

Citation: Rocco A, Nardone G. Diet, H pylori infection and gastric cancer: Evidence and controversies. World J Gastroenterol 2007; 13(21): 2901-2912
URL: https://www.wjgnet.com/1007-9327/full/v13/i21/2901.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i21.2901